Alta Schutte's Publications
About Alta Schutte's Publications
Co-Director, Global Cardiovascular Program- Program Head, Blood Pressure Research
- SHARP Professor and Principal Theme Lead: Cardiac, Vascular and Metabolic Medicine, UNSW Sydney
-
May Measurement Month 2023: results of blood pressure screening in 46 countries
European Heart Journal Supplements Date published: -
Triple drug antihypertensive single-pill combinations included as WHO essential medicines: an overview of efficacy, safety, and cost
Journal of Human Hypertension Date published: -
Patient personas exemplifying behavioural barriers and enablers to patient education across the hypertension journey: A qualitative framework analysis
Patient Education and Counseling Date published: -
Validated Automated Cuff Blood Pressure Devices for Children: STRIDE BP Report and Call to Action
Hypertension Date published: -
Home blood pressure telemonitoring reveals race-specific patterns of target organ damage
Journal of Hypertension Date published: -
Reply to comment: Limited public understanding of the risk factors and complications of hypertension
Journal of Hypertension Date published: -
Novel hypertension phenotypes based on cross-classification of 24-h brachial and aortic SBP
Journal of Hypertension Date published: -
Prevalence of target organ damage in rural Kenya and The Gambia: a cross-sectional study
The Lancet Regional Health - Africa Date published: -
Adverse Effects and Treatment Discontinuation of Blood Pressure-Lowering Drugs and Combinations
JAMA Date published: -
Update from the National Hypertension Taskforce of Australia: prevalence, treatment and control rates of hypertension between 2022 and 2024 - implications and future directions
Journal of Hypertension Date published: -
Obesity rise plateaus in developed nations and accelerates in developing nations
Nature Date published: -
The genie is out: blood pressure wearables and the evidence gap
European Journal of Preventive Cardiology Date published: -
The role of community-based blood pressure screening in improving hypertension care
The Lancet Date published: -
Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic risk
Trials Date published: -
Factors affecting hospital inpatient blood pressure measurement as ranked by a Delphi survey
Scientific Reports Date published: -
How Accurate Is Inpatient Blood Pressure Measurement?
Hypertension Date published: